AU2012259803A1 - Dry-coated tablet containing tegafur, gimeracil and oteracil potassium - Google Patents

Dry-coated tablet containing tegafur, gimeracil and oteracil potassium

Info

Publication number
AU2012259803A1
AU2012259803A1 AU2012259803A AU2012259803A AU2012259803A1 AU 2012259803 A1 AU2012259803 A1 AU 2012259803A1 AU 2012259803 A AU2012259803 A AU 2012259803A AU 2012259803 A AU2012259803 A AU 2012259803A AU 2012259803 A1 AU2012259803 A1 AU 2012259803A1
Authority
AU
Australia
Prior art keywords
gimeracil
dry
coated tablet
tablet containing
oteracil potassium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2012259803A
Other versions
AU2012259803B2 (en
Inventor
Yoshito Ohnishi
Takumi Okamoto
Takashi Yoshizawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taiho Pharmaceutical Co Ltd
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Priority claimed from PCT/JP2012/063260 external-priority patent/WO2012161240A1/en
Publication of AU2012259803A1 publication Critical patent/AU2012259803A1/en
Application granted granted Critical
Publication of AU2012259803B2 publication Critical patent/AU2012259803B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

AU2012259803A 2011-05-25 2012-05-24 Dry-coated tablet containing tegafur, gimeracil and oteracil potassium Ceased AU2012259803B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2011116884 2011-05-25
JP2011-116884 2011-05-25
PCT/JP2012/063260 WO2012161240A1 (en) 2011-05-25 2012-05-24 Dry-coated tablet containing tegafur, gimeracil and oteracil potassium

Publications (2)

Publication Number Publication Date
AU2012259803A1 true AU2012259803A1 (en) 2013-12-05
AU2012259803B2 AU2012259803B2 (en) 2016-03-17

Family

ID=47217314

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2012259803A Ceased AU2012259803B2 (en) 2011-05-25 2012-05-24 Dry-coated tablet containing tegafur, gimeracil and oteracil potassium

Country Status (15)

Country Link
US (1) US20140335174A1 (en)
EP (1) EP2716290B1 (en)
JP (2) JP5689173B2 (en)
KR (2) KR101869127B1 (en)
AU (1) AU2012259803B2 (en)
BR (1) BR112013030093B1 (en)
CA (1) CA2836865C (en)
ES (1) ES2671926T3 (en)
IL (1) IL229372B (en)
MX (1) MX353289B (en)
MY (1) MY167883A (en)
RU (1) RU2601620C2 (en)
SG (2) SG10201505503WA (en)
TW (2) TWI488659B (en)
WO (1) WO2012161240A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140335174A1 (en) * 2011-05-25 2014-11-13 Taiho Pharmaceutical Co., Ltd. Dry-coated tablet containing tegafur, gimeracil and oteracil potassium
CN107837273A (en) * 2016-09-18 2018-03-27 江苏金甙生物技术有限公司 A kind of enteric tegafur, gimeracil and oteracil potassium sustained release preparation and preparation method thereof
CN107865871B (en) * 2016-09-23 2021-09-03 江苏恒瑞医药股份有限公司 Tegiloi composition and preparation method thereof
CN106619689B (en) * 2016-12-30 2018-05-01 陈晓华 It is a kind of for the pharmaceutical composition for the treatment of cancer, kit and its application
TW202404585A (en) * 2022-06-10 2024-02-01 日商大鵬藥品工業股份有限公司 Pharmaceutical composition containing pimitespib

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992021345A1 (en) * 1991-05-27 1992-12-10 Taiho Pharmaceutical Co., Ltd. Composition, method and kit for potentiating antitumor activity and for curing tumor
WO1999044580A1 (en) * 1998-03-06 1999-09-10 Eurand International S.P.A. Fast disintegrating tablets
DE60116758T2 (en) * 2000-05-18 2006-11-02 Therics, Inc. Encapsulation of a toxic to a non-toxic region in an oral formulation
KR20040037138A (en) * 2001-09-28 2004-05-04 가부시키가이샤산와카가쿠켄큐쇼 Press-Coated Fast-Dissolving/Disintegrating Molded Product
WO2003039530A1 (en) * 2001-11-07 2003-05-15 Synthon B.V. Tamsulosin tablets
US6723348B2 (en) * 2001-11-16 2004-04-20 Ethypharm Orodispersible tablets containing fexofenadine
JP2005526095A (en) * 2002-03-20 2005-09-02 エラン ファーマ インターナショナル,リミティド Rapid dissolution dosage form with low friability
DE602004016636D1 (en) * 2003-03-14 2008-10-30 Taiho Pharmaceutical Co Ltd AN ANTITUM EFFECT INCREASING COMPOUND AND ANTITUMORANTS
AU2004275569B2 (en) * 2003-09-29 2011-04-21 Cipla Limited Pharmaceutical formulation with improved stability
CN100333726C (en) 2004-12-23 2007-08-29 鲁南制药集团股份有限公司 Disintegration piece taken through oral cavity containing Gimeracil and Oteracil Potassium with fluorine being added
TWI434700B (en) * 2005-04-01 2014-04-21 Taiho Pharmaceutical Co Ltd Radiotherapy enhancer
JP4994618B2 (en) * 2005-08-11 2012-08-08 学校法人北里研究所 Chemoradiation with TS-1 / camptothecins
JP5356255B2 (en) * 2007-12-27 2013-12-04 大鵬薬品工業株式会社 Oral powder granular antitumor agent
TWI468188B (en) * 2008-01-30 2015-01-11 Univ Tokushima Anti-cancer effect enhancers consisting of oxaliplatin liposomal preparations and anticancer agents comprising the formulation
KR100934876B1 (en) 2008-01-31 2010-01-06 성균관대학교산학협력단 Plating method for liga process
CN101380327B (en) * 2008-10-09 2011-01-26 北京恒瑞康达医药科技发展有限公司 Anti-cancer composite sustained-release composition and preparation method thereof
JP5553522B2 (en) 2009-03-31 2014-07-16 大鵬薬品工業株式会社 Pharmaceutical composition for oral administration
EP2431032A4 (en) * 2009-05-12 2012-11-07 Taiho Pharmaceutical Co Ltd Anti-tumor agent comprising tegafur-gimeracil-oteracil potassium combination drug and oxaliplatin
CN101711765B (en) * 2009-10-31 2011-03-23 山东新时代药业有限公司 Dispersing tablet containing tegafur, gimeracil and oteracil potassium
US20140335174A1 (en) * 2011-05-25 2014-11-13 Taiho Pharmaceutical Co., Ltd. Dry-coated tablet containing tegafur, gimeracil and oteracil potassium
CN102614183B (en) * 2012-03-05 2013-10-30 齐鲁制药(海南)有限公司 Oral preparation containing tegafur, gimeracil and oteracil potassium

Similar Documents

Publication Publication Date Title
IL257179A (en) Composition comprising aflibercept, folinic acid, 5-fluorouracil (5-fu) and irinocetan (folfiri)
IL242286A0 (en) Substituted n-(2-methoxy-5-nitrophenyl)pyrimidin-2-amine compounds, and salts thereof
ZA201403503B (en) Thieno- and furo - pyrimidines and pyridines, useful as potassium channel inhibitors
IL231009A0 (en) Bicyclic heteroaromatic compounds, their prepartion and pharmaceutical composition containing them
EP3084623A4 (en) Context-aware collaborative user tracking
PT2725903T (en) 3-alkoxy, thioalkyl and amino-4-amino-6-(substituted)picolinates and their use as herbicides
EP2683711B8 (en) New pyridazinone and pyridone compounds
IL229372B (en) Dry-coated tablet containing tegafur, gimeracil and oteracil potassium
AP2012006232A0 (en) New association between 4-ä3-ÄCIS-hexahydrocyclopentaÄcÜpyrrol-2(1H)-YLÜpropoxyübenzamide and an Acetylcholinesterase inhibitor, and pharmaceutical compositions containing it.
AU2012259803A1 (en) Dry-coated tablet containing tegafur, gimeracil and oteracil potassium
EP2711704A4 (en) Method for selecting chemotherapy for gastric cancer patient using combination drug of tegafur, gimeracil and oteracil potassium and egfr inhibitor
HK1161971A1 (en) A capsule preparation containing tegafur, gimeracil and oteracil potassium
HK1211481A1 (en) Dry pressed coating tablet containing tegafur, gimeracil and oteracil potassium
HK1191942A1 (en) New hexahydrocyclopentapyrrolone, hexahydropyrrolopyrrolone, octahydropyrrolopyridinone and octahydropyridinone compounds
IL229206A0 (en) Composition and tablet comprising raltegravir
HRP20160687T1 (en) Substituted 2-(chroman-6-yloxy)-thiazoles and their use as pharmaceuticals
IL231096A0 (en) Substituted 2-(chroman-6-yloxy)-thiazoles and their use as pharmaceuticals
AU2011900335A0 (en) Trolleytracka and RFID sharing solutions
AU2011902077A0 (en) Metal detector
GB201111104D0 (en) Nanodern future technology- human mental alterness, focus and concentration enhancing spray formulation
AU2012901302A0 (en) Herbicidal granule composition and method
TH126521B (en) Pharmaceutical formulation in double-layer tablet formulated with HMG-COA, reductase inhibitor and ervesartan.
AU2011901597A0 (en) Universal PC Tablet & E-Book Reader Carry Case
AU2011904936A0 (en) Bismuth compounds and uses
GB201120526D0 (en) Portfolio building and management tools adapted for internet and mobile applications use